ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunosuppression"

  • 2021 American Transplant Congress

    Immunosuppression Reduction Strategies for Polyoma BK Viremia in Kidney Transplant Patients on Belatacept-Based Immunosuppression

    O. Roe1, E. Meredith1, A. Reid2, A. Basu3

    1Emory University Hospital, Atlanta, GA, 2University of California San Francisco Medical Center, San Francisco, CA, 3Emory Transplant Center, Atlanta, GA

    *Purpose: The mainstay of treatment for BK infection is immunosuppression (IS) reduction, however limited literature provides guidance for treatment of patients with a belatacept-based IS…
  • 2021 American Transplant Congress

    Belatacept for Kidney Transplantation in the Age of Covid19, is it Safe?

    J. Pagan1, S. Anjan2, Y. Natori3, A. Fernandez3, R. Zamora-Gonzalez2, A. Mattiazzi1, L. Mendez1, G. Guerra1

    1Nephrology, University of Miami, Miami, FL, 2Infectious Diseases, University of Miami, Miami, FL, 3Infectious Disease, University of Miami, Miami, FL

    *Purpose: The COVID19 pandemic has affected kidney transplant recipients (KTR) with a wide spectrum of clinical severity. Up to this point, we have solely seen…
  • 2021 American Transplant Congress

    Remote Monitoring Using Mobile Phlebotomy and Donor-derived Cell-free DNA in Kidney Transplant Recipients During the Covid-19 Pandemic

    N. Ali1, J. Miles2, V. Tatapudi1, R. Montgomery1

    1NYU Langone, New York, NY, 2Medical Science Liason, CareDx, Brisbane, CA

    *Purpose: The rapid shift to telemedicine and remote monitoring of kidney transplant recipients (KTRs) during COVID-19 aimed to mitigate exposure risk for this vulnerable population.…
  • 2021 American Transplant Congress

    The Impact of High Kdpi on 1-year Post-transplant Graft Function and Survival in a Brazilian Cohort

    H. Tedesco Silva Junior, R. Demarchi Foresto, M. Hazin, B. Cassão, A. Aquino, J. Taddeo, C. Rosso Felipe, L. Requião Moura, J. Medina

    Núcleo de Ensino e Pesquisa, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil

    *Purpose: To evaluate the impact of High Kidney Donor Profile Index (KDPI) on 1-year post-transplant renal function and graft survival.*Methods: This retrospective cohort analyzed 3,059…
  • 2021 American Transplant Congress

    Sharp Anti-HLA Antibody Development Due to Concomitant Graft Nephrectomy and Immunosuppression Withdrawal After Early Graft Loss

    R. Valero1, A. Aguilera1, E. Rodrigo1, D. San Segundo2, M. Lopez-Hoyos2, J. Ruiz1

    1Nefrología, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2Inmunología, Hospital Universitario Marqués de Valdecilla, Santander, Spain

    *Purpose: The number of patients awaiting for retransplantation has been progressively increasing. The presence of anti-HLA antibodies can significantly lengthen the waiting time, limiting the…
  • 2021 American Transplant Congress

    Symptoms on MTSOSD Questionnaire in Pancreas Transplantation Recipients

    R. Kaur, S. R. Rizvi, B. H. Smith, C. Reid, S. K. McCrady-Spitzer, W. K. Kremers, P. G. Dean, A. Kukla, M. D. Stegall, Y. C. Kudva

    Mayo Clinic, Rochester, MN

    *Purpose: We used the Modified transplant symptom Occurrence and symptom distress scale (MTSOSD) to study side-effects of immunosuppression after Pancreas transplantation (PT) for patients with…
  • 2021 American Transplant Congress

    Outcomes of Kidney Transplantation in HIV Positive Highly Sensitized Recipients

    S. Karhadkar, J. Panichella, H. Resweber, K. Nguyen, A. Di Carlo, S. Karhadkar

    Temple University School of Medicine, Philadelphia, PA

    *Purpose: Since the introduction of highly active antiretroviral therapy, HIV+ individuals are living longer, which has led to higher rates of end stage renal disease…
  • 2021 American Transplant Congress

    The Clinical Validation of a Dried Blood Spot Method for Simultaneous Tacrolimus and Creatinine Measurement

    M. I. Francke1, S. Bouarfa2, B. van Domburg2, D. van de Velde2, M. E. Hellemons3, O. C. Manintveld4, S. M. Last-Koopmans5, M. B. Mulder2, D. A. Hesselink1, B. C. de Winter2

    1Internal medicine, nephrology and transplantation, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 2Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 3Pulmonary medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 4Cardiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 5Hematology, Erasmus MC, University Medical Center, Rotterdam, Netherlands

    *Purpose: Monitoring tacrolimus concentrations and kidney function after transplantation is important to avoid tacrolimus under- and overexposure and its clinical consequences, including acute nephrotoxicity. Using…
  • 2021 American Transplant Congress

    Tacrolimus Shortage and the Rush to Convert: An Unexpected Burden on the System During the Covid-19 Pandemic?

    N. Pilch, L. Johnson, M. Aldoughaim, N. Patel, F. Bartlett

    Medical University of South Carolina, Charleston, SC

    *Purpose: A national shortage of immediate release (IR) tacrolimus (FK) fully impacted our center in May 2020. The conversion process was immediately challenging during the…
  • 2021 American Transplant Congress

    Evaluation of Meningococcal Vaccine Response Among Solid Organ Transplant Recipients Receiving Eculizumab

    R. Arora1, C. Kane1, K. Cunningham1, M. Ison2

    1Pharmacy, Northwestern Memorial Hospital, Chicago, IL, 2Divisions of Infectious Diseases and Organ Transplantation, Northwestern Memorial Hospital, Chicago, IL

    *Purpose: Patients receiving eculizumab are at a 1,000-2,000-fold increased risk of invasive meningococcal infections. Therefore, the Advisory Committee for Immunization Practices recommends that these patients…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 138
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences